Back to today’s briefing

Story perspectives

COVID-19 Reactivates Epstein-Barr in 80.7% of MIS-C Cases

3/14/2025

33 3

Summary

Story summary

A groundbreaking study in Nature uncovers a startling link between COVID-19 and multisystem inflammatory syndrome in children (MIS-C). Researchers discovered that a staggering 80.7% of MIS-C patients showed signs of the Epstein-Barr virus reactivating, indicating that COVID-19 may unleash dormant infections, triggering intense inflammatory reactions in vulnerable young patients.

1 of 1

Story summary

A groundbreaking study in Nature uncovers a startling link between COVID-19 and multisystem inflammatory syndrome in children (MIS-C). Researchers discovered that a staggering 80.7% of MIS-C patients showed signs of the Epstein-Barr virus reactivating, indicating that COVID-19 may unleash dormant infections, triggering intense inflammatory reactions in vulnerable young patients.